"Fewer than one in 10 people who could benefit from obesity jabs like Wegovy are able to get them, warns the World Health Organization as it releases its first guidance on the drugs. With more than one billion people worldwide now obese, it is calling for more widespread and fairer access to GLP-1 medication. According to projections, more than two billion will be obese by 2030 unless action is taken."
"WHO says these drugs, sometime called skinny jabs, represent a new chapter in the gradual conceptual shift in how society approaches obesity, from a "lifestyle condition" to a complex, preventable, and treatable chronic disease. It says the drugs can be taken long-term - for six months or more - but must be prescribed along with advice on diet and exercise, so that people can keep the weight off."
Fewer than one in ten people who could benefit from GLP-1 obesity injections can access them. More than one billion people are currently obese worldwide, and projections estimate over two billion by 2030 without intervention. High costs, limited production capacity, and supply-chain constraints are major barriers to wider access. GLP-1 therapies can produce significant, long-term weight loss when prescribed alongside diet and exercise counseling. The medications have been added to the essential medicines list to encourage provision. Strategies such as voluntary licensing, expanded manufacturing, and equitable pricing are recommended to increase global availability and fairness.
Read at www.bbc.com
Unable to calculate read time
Collection
[
|
...
]